Package 51316-018-10

{"route": ["ORAL"], "spl_id": "132629da-7f70-439b-3df7-876d0aeb01ee", "openfda": {"unii": ["2S068B75ZU", "6V9V2RYJ8N"], "spl_set_id": ["3a878985-3a0e-1960-db0e-e3b8fd9d5c63"], "manufacturer_name": ["CVS Pharmacy, Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 BLISTER PACK in 1 CARTON (51316-018-10)  / 5 TABLET, EXTENDED RELEASE in 1 BLISTER PACK", "package_ndc": "51316-018-10", "marketing_end_date": "20260831", "marketing_start_date": "20221130"}, {"sample": false, "description": "3 BLISTER PACK in 1 CARTON (51316-018-15)  / 5 TABLET, EXTENDED RELEASE in 1 BLISTER PACK", "package_ndc": "51316-018-15", "marketing_end_date": "20260831", "marketing_start_date": "20221130"}], "brand_name": "Fexofenadine HCl and Pseudoephedrine HCl", "product_id": "51316-018_132629da-7f70-439b-3df7-876d0aeb01ee", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Adrenergic alpha-Agonists [MoA]", "Histamine H1 Receptor Antagonists [MoA]", "Histamine-1 Receptor Antagonist [EPC]", "alpha-Adrenergic Agonist [EPC]"], "product_ndc": "51316-018", "generic_name": "Fexofenadine HCl and Pseudoephedrine HCl", "labeler_name": "CVS Pharmacy, Inc", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Fexofenadine HCl and Pseudoephedrine HCl", "active_ingredients": [{"name": "FEXOFENADINE HYDROCHLORIDE", "strength": "180 mg/1"}, {"name": "PSEUDOEPHEDRINE HYDROCHLORIDE", "strength": "240 mg/1"}], "application_number": "ANDA079043", "marketing_category": "ANDA", "marketing_end_date": "20260831", "marketing_start_date": "20221130"}